SCHEMBL857121

SCHEMBL857121

CCCc1c(C)nc(C)nc1Cl

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 2/20 0.43
ALDH1A1 P00352 3/20 0.39
DCTPP1 Q9H773 1/20 0.35
KDM4E B2RXH2 1/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
PDK4 Q16654 1/20 0.31
TYMP P19971 1/20 0.31
KDM5A P29375 1/20 0.30
RXRA P19793 1/20 0.30
NR4A2 P43354 1/20 0.30
PDE4B Q07343 1/20 0.30
PDE4D Q08499 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17280955 0.84 ALDH1A1 (0.37) PDK2ALDH1A1DCTPP1KDM4EGAA
SCHEMBL4980998 0.83 ALDH1A1 (0.39) PDK2ALDH1A1DCTPP1KDM4EGAA
SCHEMBL857094 0.82 CYP1A2 (0.36) PDK2ALDH1A1KDM4EGAAHPGD
SCHEMBL12493933 0.81 KDM4E (0.32) PDK2ALDH1A1KDM4EHTT
SCHEMBL22994717 0.79 PDK2 (0.41) PDK2ALDH1A1KDM4EGAAHPGD
SCHEMBL30738986 0.79 PDK2 (0.41) PDK2ALDH1A1KDM4EGAAHPGD
SCHEMBL8515321 0.79 NPSR1 (0.47) ALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL4762749 0.78 PDK2 (0.40) PDK2ALDH1A1KDM4EGAAHPGD
SCHEMBL12495762 0.77 PDK2 (0.42) PDK2ALDH1A1KDM4EHPGDHTT
SCHEMBL30648000 0.76 LMNA (0.38) ALDH1A1DCTPP1HPGDHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2640366-A2 BENZOXAZEPINES AS INHIBITORS OF PI3K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE Exelixis, Inc. (US) 2013-09-25 EP disclosed
WO-2012068096-A2 BENZOXAZEPINES AS INHIBITORS OF PI3K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE EXELIXIS, INC. (US) 2012-05-24 WO disclosed
EP-2432779-A1 BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES Exelixis, Inc. (US) 2012-03-28 EP disclosed
WO-2010135524-A1 BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES EXELIXIS, INC. (US) 2010-11-25 WO disclosed